CRYSTAL WALLACE: Open Payments
NPI 1629550496 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $118 |
| Exact Sciences Corporation | 2 | $41 |
| Novo Nordisk Inc | 2 | $41 |
| Amgen Inc. | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Tris Pharma Inc | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: UBRELVY, QULIPTA, The Cologuard Plus Collection Kit, OTEZLA, Saxenda, XIFAXAN, Dyanavel XR, FUROSCIX.
Industry payments across MS — which companies pay providers there.
